Prelude Capital Management, LLC Johnson & Johnson Call Options Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $535,745 - $596,680	3,500 Added 218.75%	5,100 $838,000
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $2.36 Million - $2.71 Million	-17,200 Reduced 91.49%	1,600 $252,000
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $2.37 Million - $2.86 Million	18,400 Added 4600.0%	18,800 $2.64 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $2.06 Million - $2.85 Million	-18,500 Reduced 97.88%	400 $52,000
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $2.41 Million - $2.77 Million	18,900 New	18,900 $2.76 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $2.95 Million - $3.25 Million	-22,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $2.83 Million - $3.15 Million	22,500 New	22,500 $3.15 Million

4,473

1.73B

16.7M

14.6M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $408B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.